FTRE: מכפיל EV/EBITDA Fortrea Corp

סמל ולוגו של המותג Fortrea (FTRE)

Fortrea Holdings Inc. is expanding its laboratory network, increasing profitability through digital data collection. Production capacities are fully utilized as the company undergoes a modernization phase of its diagnostic equipment. Test efficiency is improving through the implementation of AI platforms for biodata processing. Reviewing the EV/EBITDA valuation dynamics on GURU.Markets, it is evident that 23.00 is recorded as the baseline value for this key multiple.

FTRE Fortrea Clinical: יחס שווי חברה כולל לרווח תפעולי לפני פחת בטווח 23.11.2025 - 16.11.2026

פילוחים אנליטיים של חברת Fortrea Holdings Inc.

הערכת שווי פונדמנטלית:FTRE (Fortrea Holdings Inc)
מוצר מקורי של fortrea.com

To assess the long-term risks of Fortrea Holdings Inc. (FTRE), the enterprise value to EBITDA ratio is utilized, which accounts for debt load and capitalization. The EV/EBITDA trend for this capital-intensive business allows for a comparison of operational efficiency against the market price of assets, which is critical given the saturation of the early-stage research segment in the US and the dependence on long-term pharmaceutical contracts.